 Michele Yang
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Height | 3 | 2016 | 180 | 0.640 |
Why?
| | Muscular Dystrophy, Duchenne | 4 | 2023 | 81 | 0.590 |
Why?
| | Body Weight | 3 | 2016 | 867 | 0.510 |
Why?
| | Neuromuscular Diseases | 1 | 2016 | 90 | 0.480 |
Why?
| | Child Development | 1 | 2016 | 389 | 0.390 |
Why?
| | Body Mass Index | 3 | 2016 | 1971 | 0.350 |
Why?
| | Myopathies, Structural, Congenital | 2 | 2019 | 6 | 0.330 |
Why?
| | Myelitis | 2 | 2017 | 88 | 0.260 |
Why?
| | Respiration, Artificial | 2 | 2019 | 526 | 0.240 |
Why?
| | Spinal Muscular Atrophies of Childhood | 2 | 2014 | 15 | 0.220 |
Why?
| | Motor Neurons | 2 | 2016 | 213 | 0.220 |
Why?
| | Dystrophin | 1 | 2023 | 30 | 0.220 |
Why?
| | Child, Preschool | 13 | 2020 | 9133 | 0.210 |
Why?
| | Leukodystrophy, Globoid Cell | 1 | 2020 | 8 | 0.180 |
Why?
| | Neurology | 1 | 2021 | 85 | 0.180 |
Why?
| | Patient Admission | 1 | 2021 | 175 | 0.170 |
Why?
| | Alcohol Oxidoreductases | 1 | 2019 | 38 | 0.160 |
Why?
| | Nervous System Diseases | 1 | 2021 | 253 | 0.160 |
Why?
| | Patient Safety | 1 | 2021 | 276 | 0.150 |
Why?
| | Neuroimaging | 1 | 2020 | 247 | 0.150 |
Why?
| | Premature Birth | 2 | 2019 | 278 | 0.150 |
Why?
| | Neural Conduction | 2 | 2017 | 79 | 0.150 |
Why?
| | Infant | 8 | 2020 | 7979 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2019 | 296 | 0.140 |
Why?
| | Cranial Nerve Diseases | 1 | 2017 | 42 | 0.140 |
Why?
| | Movement Disorders | 1 | 2017 | 46 | 0.140 |
Why?
| | Muscular Diseases | 1 | 2017 | 104 | 0.140 |
Why?
| | Muscle, Skeletal | 2 | 2017 | 1447 | 0.140 |
Why?
| | Muscle Weakness | 2 | 2014 | 80 | 0.130 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2020 | 366 | 0.130 |
Why?
| | Pregnenediones | 1 | 2016 | 21 | 0.130 |
Why?
| | Paralysis | 1 | 2016 | 67 | 0.130 |
Why?
| | Cohort Studies | 5 | 2020 | 4944 | 0.130 |
Why?
| | Glucocorticoids | 2 | 2020 | 552 | 0.130 |
Why?
| | Surgical Procedures, Operative | 1 | 2017 | 210 | 0.130 |
Why?
| | Respiration Disorders | 1 | 2016 | 68 | 0.130 |
Why?
| | Prednisone | 1 | 2016 | 232 | 0.120 |
Why?
| | Cytoplasmic Dyneins | 1 | 2015 | 7 | 0.120 |
Why?
| | Gastrostomy | 1 | 2016 | 89 | 0.120 |
Why?
| | Enterovirus D, Human | 1 | 2016 | 72 | 0.120 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2015 | 17 | 0.120 |
Why?
| | Infant, Newborn | 4 | 2020 | 5077 | 0.120 |
Why?
| | Survival of Motor Neuron 1 Protein | 1 | 2014 | 7 | 0.120 |
Why?
| | Enteral Nutrition | 1 | 2016 | 157 | 0.120 |
Why?
| | Enterovirus Infections | 1 | 2016 | 160 | 0.110 |
Why?
| | Polyneuropathies | 1 | 2014 | 50 | 0.110 |
Why?
| | Growth | 1 | 2013 | 56 | 0.110 |
Why?
| | Child | 12 | 2020 | 18488 | 0.110 |
Why?
| | Telemedicine | 1 | 2021 | 667 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2017 | 4440 | 0.100 |
Why?
| | Weight Gain | 1 | 2016 | 453 | 0.100 |
Why?
| | Respiratory Mechanics | 1 | 2012 | 56 | 0.100 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1316 | 0.100 |
Why?
| | Muscular Dystrophies | 1 | 2012 | 36 | 0.100 |
Why?
| | Aspartate Aminotransferases | 1 | 2012 | 87 | 0.100 |
Why?
| | Motor Skills | 1 | 2012 | 80 | 0.100 |
Why?
| | Alanine Transaminase | 1 | 2012 | 141 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 2 | 2020 | 3069 | 0.100 |
Why?
| | Action Potentials | 1 | 2014 | 410 | 0.090 |
Why?
| | Male | 13 | 2021 | 55949 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2392 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 1829 | 0.090 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 476 | 0.090 |
Why?
| | Muscle Strength | 1 | 2012 | 275 | 0.090 |
Why?
| | Critical Illness | 1 | 2014 | 645 | 0.080 |
Why?
| | Humans | 17 | 2023 | 115587 | 0.080 |
Why?
| | Adolescent | 8 | 2020 | 17889 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2019 | 12608 | 0.080 |
Why?
| | Female | 10 | 2021 | 59913 | 0.070 |
Why?
| | Young Adult | 6 | 2020 | 10470 | 0.070 |
Why?
| | Mutation | 1 | 2015 | 3364 | 0.060 |
Why?
| | Electromyography | 2 | 2017 | 324 | 0.060 |
Why?
| | Sarcolemma | 1 | 2023 | 29 | 0.050 |
Why?
| | Utrophin | 1 | 2023 | 7 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 326 | 0.050 |
Why?
| | Age Factors | 2 | 2019 | 2907 | 0.050 |
Why?
| | Disease Progression | 2 | 2020 | 2418 | 0.050 |
Why?
| | Tooth Abnormalities | 1 | 2019 | 12 | 0.040 |
Why?
| | Phenotype | 2 | 2019 | 2829 | 0.040 |
Why?
| | Muscle Hypotonia | 1 | 2019 | 31 | 0.040 |
Why?
| | Ataxia | 1 | 2019 | 35 | 0.040 |
Why?
| | Adult | 5 | 2021 | 30718 | 0.040 |
Why?
| | Prospective Studies | 3 | 2014 | 6264 | 0.040 |
Why?
| | Intellectual Disability | 1 | 2019 | 129 | 0.040 |
Why?
| | Stroke Volume | 1 | 2020 | 509 | 0.040 |
Why?
| | Echocardiography | 1 | 2020 | 558 | 0.040 |
Why?
| | Atrophy | 1 | 2017 | 152 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2416 | 0.030 |
Why?
| | Glioblastoma | 1 | 2019 | 253 | 0.030 |
Why?
| | Alleles | 1 | 2019 | 794 | 0.030 |
Why?
| | Middle Aged | 4 | 2021 | 26999 | 0.030 |
Why?
| | Brain | 2 | 2020 | 2370 | 0.030 |
Why?
| | Mortality | 1 | 2017 | 290 | 0.030 |
Why?
| | Chromatin | 1 | 2019 | 429 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2017 | 250 | 0.030 |
Why?
| | Fibroblasts | 1 | 2019 | 839 | 0.030 |
Why?
| | Sural Nerve | 1 | 2014 | 19 | 0.030 |
Why?
| | Peroneal Nerve | 1 | 2014 | 19 | 0.030 |
Why?
| | Neurologic Examination | 1 | 2014 | 116 | 0.030 |
Why?
| | Homozygote | 1 | 2014 | 186 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 958 | 0.030 |
Why?
| | Electrophysiology | 1 | 2014 | 202 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 1917 | 0.030 |
Why?
| | Exons | 1 | 2014 | 300 | 0.030 |
Why?
| | Proteomics | 1 | 2019 | 859 | 0.030 |
Why?
| | Leg | 1 | 2015 | 227 | 0.030 |
Why?
| | Clinical Enzyme Tests | 1 | 2012 | 11 | 0.030 |
Why?
| | Gene Deletion | 1 | 2014 | 355 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 2751 | 0.030 |
Why?
| | Unnecessary Procedures | 1 | 2012 | 43 | 0.030 |
Why?
| | Incidental Findings | 1 | 2012 | 76 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1870 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 776 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2019 | 980 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2012 | 220 | 0.020 |
Why?
| | Family | 1 | 2015 | 594 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2377 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2014 | 622 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3022 | 0.020 |
Why?
| | Sepsis | 1 | 2014 | 515 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 8697 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4113 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2015 | 6417 | 0.010 |
Why?
| | Biomarkers | 1 | 2012 | 3466 | 0.010 |
Why?
| | Quality of Life | 1 | 2012 | 2385 | 0.010 |
Why?
| | Animals | 1 | 2023 | 32102 | 0.010 |
Why?
| | United States | 1 | 2016 | 12295 | 0.010 |
Why?
| | Aged | 1 | 2014 | 19251 | 0.010 |
Why?
|
|
Yang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|